Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiac477 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Hatasu Kobayashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Molnupiravir is an antiviral agent recently used for treating coronavirus disease 2019 (COVID-19). Here, we demonstrate that N4-hydroxycytidine (NHC), a molnupiravir metabolite, treated with cytidine deaminase (CDA) induced Cu(II)-mediated oxidative DNA damage in isolated DNA. A colorimetric assay revealed hydroxylamine generation from CDA-treated NHC. The site specificity of DNA damage also suggested involvement of hydroxylamine in the damage. Furthermore, Cu(I) and H2O2 play an important role in the DNA damage. We propose oxidative DNA damage via CDA-mediated metabolism as a possible mutagenic mechanism of NHC, highlighting the need for careful risk assessment of molnupiravir use in therapies for viral diseases, including COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
- Faculty of Pharmacy, Gifu University of Medical Science, Kani, Japan.
- Mie Prefectural College of Nursing, Tsu, Japan.
- Radioisotope Experimental Facility, Advanced Science Research Promotion Center, Mie University, Tsu, Japan.
- Faculty of Pharmaceutical Science, Suzuka University of Medical Science, Suzuka, Japan.
Förderung
- JSPS KAKENHI
Zitieren
APA
Kobayashi, H., Mori, Y., Ahmed, S., Hirao, Y., Kato, S., Kawanishi, S., Murata, M., & Oikawa, S. (2023). Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac477
Vancouver
Kobayashi H, Mori Y, Ahmed S, Hirao Y, Kato S, Kawanishi S, et al. Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiac477
BibTeX
@article{Kobayashi2023,
author = {Kobayashi, Hatasu and Mori, Yurie and Ahmed, Sharif and Hirao, Yuichiro and Kato, Shinya and Kawanishi, Shosuke and Murata, Mariko and Oikawa, Shinji},
title = {Oxidative DNA Damage by N 4-hydroxycytidine, a Metabolite of the SARS-CoV-2 Antiviral Molnupiravir},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiac477}
}
EUVIMED